BP-1-102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways

BP-1-102, a novel inhibitor of signal transducer and activator of transcription 3 (STAT3), exhibits significant antitumor effects in several malignancies in vitro and in vivo. However, its role in gastric cancer (GC) remains to be elucidated. In the present study, the effect and potential molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiaoxia, Tang, Jian, Wu, Mengjie, Chen, Shitu, Xu, Zhenzhen, Wang, Haiyong, Wang, Haohao, Yu, Xiongfei, Li, Zhongqi, Teng, Lisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423579/
https://www.ncbi.nlm.nih.gov/pubmed/30720080
http://dx.doi.org/10.3892/mmr.2019.9892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423579/
https://www.ncbi.nlm.nih.gov/pubmed/30720080
http://dx.doi.org/10.3892/mmr.2019.9892

Ejemplares similares